American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 911-912 , May 2009

Plasma and Peritoneal Dialysate Levels During Daptomycin Therapy for Peritonitis

  • Dmytro Khadzhynov, MD

      Affiliations

    • Charité Universitätsmedizin Berlin, Charité Campus Mitte, Humboldt University, Berlin, Germany
    • ,
  • Christian Joukhadar, MD

      Affiliations

    • J&P Medical Research Ltd, Vienna, Austria
    • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Harm Peters, MD

      Affiliations

    • Charité Universitätsmedizin Berlin, Charité Campus Mitte, Humboldt University, Berlin, Germany

References 

  1. Wong SS, Ho PL, Yuen KY. Evolution of antibiotic resistance mechanisms and their relevance to dialysis-related infections. Perit Dial Int. 2007;27(suppl 2):S272–S280
  2. Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: A lipopeptide antibiotic for the treatment of serious gram-positive infections. J Antimicrob Chemother. 2005;55:283–288
  3. Roveta S, Marchese A, Schito GC. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents. 2008;31:321–328
  4. Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother. 2004;48:2799–2807
  5. Kern WV. Daptomycin: First in a new class of antibiotics for complicated skin and soft-tissue infections. Int J Clin Pract. 2006;60:370–378
  6. Burkhardt O, Joukhadar C, Traunmuller F, Hadem J, Welte T, Kielstein JT. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother. 2008;61:224–225

PII: S0272-6386(09)00517-4

doi: 10.1053/j.ajkd.2009.02.017

American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 911-912 , May 2009

Article Tools

* Image Usage & Resolution